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Significance and impact of the study  18 
Biofilms are tolerant to antimicrobial treatments and can lead to severe infections. Finding new anti-19 
biofilm strategies and understanding their mode-of-action is therefore of high importance. Historically, 20 
antimicrobial testing has focused on measuring efficacy. While kill data are undeniably important, 21 
measuring biofilm dispersal provides equally useful information. Starting with biofilm grown in the 22 
same reactor, we paired assessment of biofilm removal using a new treatment- flow-cell and real-time 23 
microscopy with kill data collected using the single tube method (ASTM method E2871). Pairing these 24 
two methods revealed efficient biofilm removal properties of Penicillin G which were not detected 25 
during efficacy testing. 26 
 27 
Abstract  28 
Biofilms are microbial aggregates that show high tolerance to antibiotic treatments in vitro and in vivo. 29 
Killing and removal are both important in biofilm control, therefore methods that measure these two 30 
mechanisms were evaluated in a parallel experimental design. Kill was measured using the single tube 31 
method (ASTM method E2871) and removal was determined by video microscopy and image analysis 32 
using a new treatment flow cell.  The advantage of the parallel test design is that both methods used 33 
biofilm covered coupons harvested from a CDC biofilm reactor, a well-established and standardized 34 
biofilm growth method. The control Staphylococcus aureus biofilms increased by 0.6 logs during a 3 h 35 
contact time to medium lacking antibiotic. Efficacy testing showed biofilms exposed to 400 µmol l-1 36 
penicillin G decreased by only 0.3 logs. Interestingly, time-lapse confocal scanning laser microscopy 37 
revealed that penicillin G treatment dispersed the biofilm despite being an ineffective killing agent. In 38 
addition, no biofilm removal was detected when assays were performed in 96-well plates.  These 39 
results illustrate that biofilm behavior and impact of treatments can vary substantially when assayed by 40 
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different methods.  Measuring both killing and removal with well-characterized methods will be crucial 41 
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Microbial biofilms exhibit increased tolerance to treatment with disinfectants and antibiotics, 54 
and often, only combinations of chemical and physical measures can reduce viable cell numbers and/or 55 
remove biofilm from surfaces . Killing viable cells is the focus of traditional antibiotic therapy, 56 
although, removal of the matrix and/or prevention of initial attachment events are potentially important 57 
mechanisms in the battle to control biofilm. Currently for a medical device colonized with biofilm, 58 
replacement is often the only option to reestablish proper functionality resulting in high socioeconomic 59 
burdens for patients and health care systems (Wilkins et al., 2014).  60 
In vivo, biofilms grow in a diverse range of conditions and in vitro biofilms must therefore be 61 
studied using laboratory systems that model various conditions. Static systems, such as well-plates, 62 
grow biofilm under batch conditions (no replenishment of the nutrients) and minimal fluid shear. In a 63 
dynamic system, the nutrients are continuously replenished, and the fluid shear may vary from laminar 64 
to turbulent flow, depending upon the reactor system (Crusz et al., 2012). Flow cells are a useful tool 65 
for facilitating detailed investigations of initial attachment events and biofilm removal, both important 66 
aspects of biofilm control strategies. The preference for using dynamic assay systems is reflected by 67 
US FDA regulatory guidelines for testing medical devices containing antimicrobials (Food and Drug 68 
Administration, 2015).  69 
ASTM method E2871-13, a biofilm efficacy test generally known as the single tube method, 70 
and ASTM method E2562-17 which describes how to grow a biofilm in the CDC biofilm reactor 71 
(ASTM International, 2013; ASTM International, 2017) were developed and statistically validated for 72 
measuring the efficacy of biocides against biofilm bacteria. The CDC biofilm reactor design allows for 73 
flexibility regarding biofilm growth conditions and sampling regimes due to the placement of three 74 
removable coupons in each of eight rods (Goeres et al., 2005; Buckingham-Meyer et al., 2007). By 75 
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design, the single-tube method only measures the efficacy of biocides and antibiotics against biofilm. 76 
The single tube method is a static test system and does not provide information on biofilm removal. To 77 
address this limitation of the single tube method, the treatment-flow-cell (FC310; Biosurface 78 
Technologies, Bozeman, USA) was designed as a complementary new tool (Fig. 1). The treatment-79 
flow-cell can be used to assess biofilm removal in real time that results from treatment of a mature 80 
biofilm grown on coupons harvested from the CDC reactor. Using both, the single tube method and the 81 
treatment flow cell in parallel allows a researcher to assess the kill and/or removal that results when a 82 
biofilm is exposed to an antibiotic or biocide, thereby providing key insights into the mechanism of 83 
action.     84 
This paper highlights the advantages of combining kill and removal biofilm assays when 85 
finding new biofilm control strategies. Our treatment-flow-cell experiments, carried out in combination 86 
with the single tube method, allowed us to identify the effective biofilm removal properties of 87 
Penicillin G (Pen G) against a mature Staphylococcus aureus (S. aureus) biofilm. To our knowledge, 88 
this antibiofilm property of Pen G has not been reported yet.  89 
 90 
Results and Discussion 91 
Growth performance and Pen G susceptibility of planktonic S. aureus AH2547 92 
Planktonic S. aureus AH2547 had a generation time of 25 min, which lies in the normal 93 
bacterial proliferation range despite the metabolic burden of GFP expression (Domingue et al., 1996). 94 
A concentration of 0.15 µmol l-1 Pen G inhibited growth of the strain (Fig. 2A). We detected a 95 
difference in growth curve development for the treated versus control bacteria after 90 minutes of 96 
incubation (Fig. 2A). Due to the mode-of-action of Pen G no rapid bactericidal effect was detected, 97 
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similar to previous experiments involving Pen G and the S. aureus strain ATCC 25923  (Ausbacher et 98 
al., 2014).  99 
Treatment-flow-cell biofilm experiments and image analysis 100 
Coupons containing S. aureus AH2547 biofilm grown in the CDC reactor were collected for either 101 
efficacy testing according to the single tube method or placement into the treatment-flow-cell to assess 102 
removal. This allowed for the parallel measurement of biofilm killing and biofilm removal eliminating 103 
any experiment-to-experiment variability that is possible if the biofilm had been grown in different 104 
reactors on different days. Our microscopy studies showed that treatment with full-strength TSB in the 105 
treatment-flow-cell did not affect S. aureus biofilms. However, we observed a slight decrease of 106 
fluorescence intensity over time when performing image analysis. This can be attributed to bleaching 107 
from repeated laser light exposure (Fig. 2B, controls of experiments 1-3). Images of the untreated 108 
control coupons showed no removal events (Fig. 2C and supplementary videos S1-2). We used 400 109 
µmol l-1 of Pen G during our biofilm experiments based upon data from previous studies where equally 110 
high concentrations had only a low to moderate impact on biofilm viability (Ausbacher et al., 2014; 111 
Manner et al., 2015). Exposing the biofilm to Pen G first caused erosion of the biofilm and finally 112 
resulted in complete removal of the biofilm after 40 min, 100 min or 120 min (Fig. 2 B-C and 113 
supplementary video S2). Image analysis showed a 60% to 100% biofilm removal within a 90 minute 114 
time period. In contrast, growth curves of untreated controls and Pen G treated planktonic bacteria 115 
followed each other for 90 min due to the antibiotic’s dependence on proliferating bacteria (Fig. 2A). 116 
Even though there is a discrepancy in Pen G concentration, it has been reported that increased 117 
penicillin dosing does not necessarily impact the effect of β-lactam antibiotics (Van Herendael et al., 118 
2012). We conducted our experiments in full strength TSB and the flow of nutrients facilitated 119 
hydrodynamic interactions. The increased mass transfer, higher shear forces and the additional 120 
influence of Pen G, may therefore account for the substantial biofilm removal, which represents a 121 
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cohesive material failure (Brindle et al., 2011). Physicochemical interaction of Pen G with the biofilm 122 
is plausible, considering that Pen G has surface active properties and is capable of forming micelles 123 
(Thakkar et al., 1971). Of note, Brindle et al have made similar observations when testing an urea 124 
treatment, which in itself is not antimicrobial, against S. epidermidis biofilms (Brindle et al., 2011). In 125 
the study, urea removed biofilm within minutes when applied in conjunction with flow whereas a static 126 
soak and subsequent fluid shear challenge did not result in biofilm removal. Besides urea, the anionic 127 
surfactant SDS, chloride and chlorine-releasing agents have also been reported as having good removal 128 
properties when Pseudomonas aeruginosa biofilms were treated (Chen et al., 2000). The dispersal of 129 
the S. aureus biofilm might however be the result of a synergistic combination of bacteria/matrix 130 
response to the presence of Pen G and demonstrates the benefits of testing in a system with 131 
hydrodynamics. 132 
 133 
Single tube method 134 
It was advantageous that we could investigate the effect of Pen G on biofilms collected from the 135 
same reactor as those used in the treatment-flow cell due to the 24 available coupons in the CDC 136 
biofilm reactor. Pen G had a bacteriostatic effect on the biofilm bacteria with a difference of 0.3 log 137 
units between 1 and 3 hours of treatment (Fig. 3A). In contrast, bacteria in the untreated control 138 
biofilms proliferated under these conditions with a log increase of 0.6. 139 
The viable plate count data collected during the single tube method experiments suggest that the 140 
observed biofilm removal cannot be explained by a decrease in bacterial viability. Data from our OD600 141 
measurements (Fig. 2A) illustrate that Pen G, whose efficacy depends on dividing bacteria, does not 142 




96-well plate biofilm assay 145 
In order to check the treatment behavior of AH2547 biofilms in other assay systems we chose a 146 
96-well plate format. The 96-well plate is a favorable tool for drug screening and is commonly used by 147 
many laboratories for detecting potential anti-biofilm compounds. In this static assay system we tested 148 
if Pen G treatment led to fluorescence loss due to biofilm removal and/or cell lysis. The well-plate 149 
experiments did not result in substantial biofilm removal or loss in fluorescence after exchange of the 150 
planktonic phase (Fig. 3B). In contrast to the treatment flow cell, increased mass transfer and shear 151 
forces are absent in a 96 well-plate assay, similar to the single tube method. Lack of Pen G potency in 152 
equally high concentrations against biofilms of various S. aureus strains in well-plate based assays has 153 
been reported by others groups (Amorena et al., 1999; Pettit et al., 2009; Ausbacher et al., 2014; 154 
Manner et al., 2015). This suggests that the sole presence of 400 µmol l-1 of Pen G does not trigger 155 
biofilm removal. S. aureus biofilms grown in a 96-well format in the presence of high concentrations of 156 
Pen G can provoke protein expression for the increased energy supply for strengthening of the 157 
proteoglycan (Savijoki et al., 2016). In addition to this defense strategy, Pen G is suspected to induce 158 
dormancy and  thus support biofilm  sustainability (Savijoki et al., 2016). Further studies are needed to 159 
fully elucidate the molecular bases of the biofilm dispersing mechanism of Pen G on S. aureus 160 
biofilms. 161 
We demonstrated the usefulness of the treatment-flow-cell for visualizing biofilm removal in 162 
real-time. The ability to use coupons collected from the same CDC reactor for both the treatment flow 163 
cell and single tube method efficacy test allows for a more comprehensive evaluation of the 164 
mechanisms of action of potential antibiofilm treatments. Furthermore, our case study provides a good 165 
example of the importance of using multiple methods to reveal potent removal properties of Pen G, 166 
which has not been reported previously. The implementation of different test regimens can therefore be 167 
pivotal in identifying new biofilm control strategies.     168 
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Material and Methods 169 
Bacterial strain 170 
We used the green fluorescent protein (GFP) expressing S. aureus strain AH2547 which and 171 
contains the GFP-expressing plasmid pCM29 (Pang et al., 2010) kindly provided by Dr. Alex Horswill.  172 
 173 
Planktonic growth analysis and Pen G susceptibility   174 
Overnight cultures of S. aureus AH2547 were prepared in TSB, supplemented with 175 
chloramphenicol (10 µg/mL) for plasmid retention. Growth analyses of AH2547 were conducted in a 176 
50 mL broth volume, supplemented with chloramphenicol as described above. The OD600 values of 177 
aliquots were measured every 30 min and plated on TSA agar for CFU/mL determination. Generation 178 
time was calculated from the log-phase of AH2547 proliferation. Growth curves of treated and 179 
untreated bacteria were determined with a Biotek Synergy HT microplate reader (Biotek Instruments 180 
Inc., Winooski, VT, USA) in a 96-well plate format as described by Ausbacher et al. (Ausbacher et al., 181 
2014). 182 
 183 
Formation of 48 h biofilms in CDC reactor 184 
Biofilms were formed on glass coupons (diameter 1.27 cm) according to a modification of 185 
ASTM Method E2562-17 and Buckingham-Meyer et al. (Buckingham-Meyer et al., 2007; ASTM 186 
International, 2017). In brief, a CDC reactor containing 500 ml full strength TSB and chloramphenicol 187 
(10 µg/mL) was inoculated with 1 mL of a 109 CFU/mL overnight GFP S. aureus culture grown in full 188 
strength TSB supplemented with 10 mg/mL chloramphenicol for plasmid retention. The biofilm grew 189 
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in batch conditions at 37°C, 125 rpm for 24 h. Continuous flow of one-tenth TSB was applied 190 
subsequently for another 24 h at 37°C and 125 rpm before coupons were sampled from the reactor.  191 
 192 
Treatment-flow-cell and confocal microscopy 193 
Coupons were transferred to the treatment-flow-cell (model FC310; Biosurface Technologies, 194 
Bozeman, Mt, USA) with the low shear side up (side that faced the reactor wall). A flow of full 195 
strength TSB (2 ml/min, 37°C) was applied for three minutes to stabilize the system and for adjusting 196 
instrument settings. Untreated controls were treated with TSB. The penicillin G treatment (400 µmol l-1 197 
Pen G in TSB) was applied after the system was stable. The pH of TSB was not affected by the 198 
presence of the antibiotic (Table 1). Images were acquired of the bright field and GFP channel using a 199 
Leica SP5 confocal laser scanning microscope. The z-stack step size was set to 10 µmol l-1. Movie 200 
generation was carried out with IMARIS® (Bitplane) and image analysis with MetaMorph® 201 
(Molecular Devices). The FIJI software bundle was used for generating overlay images (Schindelin et 202 
al., 2012). 203 
 204 
Single tube method for treatment efficacy testing   205 
ASTM Method E2871, generally known as the single tube method, was used to quantitatively 206 
measure the log reduction in viable biofilm cells exposed to a Pen G for 1 h, 2 h and 3 h (ASTM 207 
International, 2013). Briefly, coupons containing S. aureus biofilm were removed from the CDC 208 
reactor, rinsed and then transferred to 50 ml conical tubes with tweezers. Subsequently, 4 mL of TSB 209 
or 400 µmol l-1 Pen G prepared in TSB were carefully added to the tubes. The tubes were incubated at 210 
37°C under static conditions. At each specific time point, 36 mL D/E broth was added and the biofilm 211 
was disaggregated by sonication and vortexing according to ASTM E2871. All tubes were kept on wet 212 
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ice and each sample was diluted immediately to neutralize the Pen G. The diluted samples were drop 213 
plated on TSA plates, incubated overnight at 37°C and enumerated.     214 
 215 
Biofilm formation and treatment in 96-well plates 216 
We performed a similar static assay in 96-well plates to investigate if a comparable effect was 217 
found in another test system commonly used in biofilm research. Biofilms were formed and treated as 218 
described by Ausbacher et al. (Ausbacher et al., 2014). After treatment, the biofilm GFP fluorescence 219 
was measured using a BioTek Synergy H1 (Biotek Instruments Inc., Winooski, VT, USA), multi-mode 220 
plate reader. 221 
 222 
Statistics 223 
The Students t-test was performed using the quantitative data from the single-tube method and 224 
96-well plate assays using SigmaPlot 13.0. 225 
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Supporting information 291 
S. aureus biofilm containing coupons, sampled from a CDC biofilm reactor, were transferred to the 292 
treatment-flow-cell with the low shear side up. TSB (2 ml/min, 37°C) was applied for three minutes to 293 
stabilize the system and continued for our untreated controls. Once stabilized, the treated coupons were 294 
exposed to 400 µmol l-1 Pen G in flowing TSB. Images were acquired with a Leica SP5 confocal laser 295 
scanning microscope using transmission and GFP channels. The z-stack step size was set to 10 µm and 296 
movie generation was carried out with IMARIS® (Bitplane, South Windsor, CT, USA). 297 
 298 
Video S1: Video microscopy of experiment 2 – Pen G 400 µmol l-1 (GFP and brightfield channels) 299 
Video S2: Video microscopy of experiment 2 – untreated control (GFP and brightfield channels)  300 
15 
 
Figure legends  301 
 302 
Fig. 1 Cross section and top view of the treatment flow cell illustrating coupon location, flow in- and 303 
outlet and mounting notches for attachment to the microscope stage. The treatment flow cell is sealed 304 
by a 25 mm cover slip, which is located under the silicon gasket, after the cap had been screwed on the 305 
bottom part of the cell. Barb ports accommodate 3 mm tubing for inlet and outlet (schematic adapted 306 
with permission from Biosurface Technologies Corp.). 307 
 308 
Fig. 2 Behavior of planktonic S. aureus, image analysis data and CLSM overlay images after real-time 309 
image acquisition of treated S. aureus biofilms. (A) Pen G (0,15 µmol l-1) treated and untreated 310 
planktonic S. aureus over an incubation period of 24 h, Pen G 400 µmol l-1 (●) and  untreated control 311 
(○). (B) Image analysis of untreated S. aureus biofilms and after treatment with 400 µmol l-1 of Pen G 312 
in three independent experiments. Experiment 1-Pen G (●), experiment 1 – control (○), experiment 2-313 
Pen G (▲), experiment 2-control (Δ), experiment 3-Pen G (■), experiment 3-control (□). For clarity, 314 
data points of each experiment were connected. (C) GFP-brightfield overlay images of control biofilms 315 
and Pen G treated biofilms at experiment start (0 min), start of erosion (40 min) and during dispersion 316 
phase (85 – 110 min). Scale bars represent 200 µmol l-1. Movies of Pen G treated and untreated 317 
biofilms are available as supplemental information in the online version of this article (videos S1-S2). 318 
 319 
Fig. 3 Quantification of the Pen G impact on S. aureus biofilms. (A) Quantification of viable cells of 320 
mature biofilms from a CDC biofilm reactor by using the single-tube method. ( ) untreated control, 321 
( ) 400 µmol l-1 Pen G. Asterisk indicates significant difference, p < 0.05 (Student’s t-test). (B) 322 
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Quantification of 18 h biofilms in 96-well plates utilizing GFP fluorescence of S. aureus. Treatment of 323 
biofilms for 1 – 3 h were followed by exchange of the planktonic phase, which did not lead to removal 324 
of biofilms in 96-well plates. Results display the mean ± SD of three independent experiments.  325 
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